Mar 24, 2014
Hemispherx Biopharma, Inc. Presented Clinical Interpretations on CFS Treatment at the 11th Biennial International Research and Clinical Conference
Mar 19, 2014
Hemispherx Biopharma, Inc. to Present Clinical Interpretations on CFS Treatment at the 11th Biennial International Research and Clinical Conference
Mar 14, 2014
HEMISPHERX BIOPHARMA ANNOUNCES FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2013
Mar 10, 2014
Hemispherx Biopharma Announces Plans to File for Regulatory Approval of Ampligen® to Treat Chronic Fatigue Syndrome (CFS) in Three Additional Latin America Countries
Mar 10, 2014
Hemispherx Biopharma Wins Federal Lawsuit Regarding Investment Banking Fees
Feb 24, 2014
Hemispherx Biopharma Publishes Full National Press Club Presentation on Corporate Website
Feb 04, 2014
Hemispherx Biopharma Summarizes Clinical Results Presented in Washington, DC on January 30, 2014 in Conjunction with the American Society for Microbiology (ASM) Biodefense Conference Aimed at Developing a Universal Influenza Vaccine to Prevent Pandemic Influenza Threat
Jan 28, 2014
A Clinical Update on the Search for a Universal Flu Vaccine: Presentation in Washington, DC on January 30, 2014 in Conjunction with the American Society for Microbiology (ASM) Biodefense Conference
Jan 22, 2014
Hemispherx Analysis of New Data on Protection from Pulmonary Damage Associated with Infection by Highly Pathogenic Influenza Virus
Jan 21, 2014
Hemispherx Presents New Data on Protection from Pulmonary Damage Associated with Infection by Highly Pathogenic Influenza Virus
 1   2   3     4    5 
 <<   <   >   >>